top of page

High on-treatment platelet
reactivity (HTPR) to aspirin and clopidogrel

Many patients on standard dual antiplatelet therapy exhibit high on-treatment platelet reactivity (HTPR) , a risk factor for post-procedural thrombotic events.

Multiplate helps clinicians detect inadequate platelet inhibition early.

Platelet function testing can identify patients who may benefit from tailored antiplatelet therapy

Related Resources

Customer Brief

Customer brief summarising key findings and the Value of Multiplate

LinkedIn Post

LinkedIn post introducing this study and inviting discussion.

Journal Article

Uzundere, O., Yargı, M., Topalel, S. et al. Triple-dose bolus versus continuous infusion of tranexamic acid: impacts on clinical outcomes in isolated coronary artery bypass surgery. J Cardiothorac Surg 21, 136 (2026). https://doi.org/10.1186/s13019-026-03877-5

Want to discuss  a research project?

Our team is here to help.

bottom of page